Insulin Degludec Patent Expiration

Insulin Degludec is used for lowering blood pressure and treating heart failure and kidney problems. It was first introduced by Novo Nordisk Inc in its drug Tresiba on Sep 25, 2015.


Insulin Degludec Patents

Given below is the list of patents protecting Insulin Degludec, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tresiba US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism Jul 17, 2026 Novo
Tresiba US10357616 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo
Tresiba US10376652 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Tresiba US6899699 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo
Tresiba US7615532 Insulin derivatives Jun 28, 2029 Novo
Tresiba US7686786 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo
Tresiba US7762994 Needle mounting system and a method for mounting a needle assembly May 23, 2024

(Expired)

Novo
Tresiba US8579869 Needle mounting system and a method for mounting a needle assembly Jun 30, 2023

(Expired)

Novo
Tresiba US8672898 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo
Tresiba US8684969 Injection device with torsion spring and rotatable display Oct 20, 2025 Novo
Tresiba US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo
Tresiba US9108002 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Tresiba US9132239 Dial-down mechanism for wind-up pen Feb 01, 2032 Novo
Tresiba US9457154 Injection device with an end of dose feedback mechanism Sep 27, 2027 Novo
Tresiba US9486588 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo
Tresiba US9616180 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Tresiba US9687611 Injection device with torsion spring and rotatable display Feb 27, 2027 Novo
Tresiba US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo
Tresiba US9861757 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo
Tresiba USRE46363 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳